One of the most remarkable findings in recent years has been that the vast majority of CRC patients carry mutations in one of two genes involved in the canonical Wnt/β-catenin signaling pathway [26–28], namely, the APC and β-catenin (CTNNB1) [29] genes. The gene discussed is CTNNB1; the disease is colorectal carcinoma.